Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy
- PMID: 31289957
- DOI: 10.1007/s10147-019-01479-x
Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy
Abstract
Background: To clarify the frequency and predictors of detecting early locoregional recurrence/disease progression (LR/DP) during the interval between surgery and postoperative adjuvant radiotherapy with/without chemotherapy in patients with oral squamous cell carcinoma.
Methods: Data on 65 patients who had undergone the initial radical surgery for previously untreated oral squamous cell carcinoma which were scheduled to receive adjuvant radiotherapy with/without chemotherapy were reviewed.
Results: Of the 65 patients, 63 (97%) were margin-positive/close and/or extracapsular extension-positive (hereinafter, high-risk factors). Eighteen (28%) patients had abnormal findings suggestive of LR/DP on postoperative imaging. Fifteen (23%) patients were diagnosed with LR/DP and treatment policy was changed. Univariate and multivariate analyses revealed higher frequencies of abnormal findings suggestive of LR/DP (univariate/multivariate analysis, p = 0.020/0.036), diagnosing of LR/DP, and changing the treatment policy (univariate/multivariate analysis, p = 0.042/0.046), among the patients who underwent postoperative diagnostic imaging tests or radiotherapy-planning contrast-enhanced (CE) CT without diagnostic imaging tests as compared with those who underwent radiotherapy-planning non-CECT without such tests.
Conclusion: The frequency of detecting of early LR/DP before postoperative adjuvant treatment in oral squamous cell carcinoma patients with high-risk factors was high. Furthermore, postoperative diagnostic imaging tests and radiotherapy-planning CECT may be useful to detect early LR/DP in oral squamous cell carcinoma patients before postoperative adjuvant therapy.
Keywords: Adjuvant radiotherapy; Oral; Postoperative; Recurrence; Squamous cell carcinoma; Surgery.
Similar articles
-
Predictors of locoregional recurrence in early stage oral cavity cancer with free surgical margins.Oral Oncol. 2010 Jan;46(1):49-55. doi: 10.1016/j.oraloncology.2009.10.011. Epub 2009 Dec 14. Oral Oncol. 2010. PMID: 20005769
-
[Patterns of recurrence in patients with stage Ⅲ thoracic esophageal squamous cell carcinoma after radical resection].Zhonghua Zhong Liu Za Zhi. 2017 Jan 23;39(1):48-55. doi: 10.3760/cma.j.issn.0253-3766.2017.01.010. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28104034 Chinese.
-
Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.Anticancer Res. 2016 Feb;36(2):785-92. Anticancer Res. 2016. PMID: 26851040
-
Evaluating the effectiveness of adjuvant radiotherapy in addition to surgery versus surgery alone at improving oncologic outcomes for early stage buccal carcinoma: a systematic review.J Otolaryngol Head Neck Surg. 2019 Dec 30;48(1):73. doi: 10.1186/s40463-019-0396-x. J Otolaryngol Head Neck Surg. 2019. PMID: 31888737 Free PMC article.
-
Effect of adjuvant radiotherapy on the local recurrence of oral squamous cell carcinoma with perineural invasion: A systematic review.Clin Otolaryngol. 2019 Mar;44(2):131-137. doi: 10.1111/coa.13239. Epub 2018 Oct 30. Clin Otolaryngol. 2019. PMID: 30295408 Free PMC article.
Cited by
-
The impact of national holidays on postoperative radiotherapy of squamous cell carcinoma of the head and neck.Clin Transl Radiat Oncol. 2023 Aug 8;42:100668. doi: 10.1016/j.ctro.2023.100668. eCollection 2023 Sep. Clin Transl Radiat Oncol. 2023. PMID: 37608964 Free PMC article.
-
Induction chemotherapy with paclitaxel, carboplatin, and cetuximab (PCE) followed by chemoradiotherapy for unresectable locoregional recurrence after curative surgery in patients with squamous cell carcinoma of the head and neck.Front Oncol. 2024 Jul 1;14:1420860. doi: 10.3389/fonc.2024.1420860. eCollection 2024. Front Oncol. 2024. PMID: 39011480 Free PMC article.
-
Prognostic importance of DNA from human papillomavirus in patients with oral squamous cell carcinoma.Med Oral Patol Oral Cir Bucal. 2022 Mar 1;27(2):e150-e158. doi: 10.4317/medoral.25092. Med Oral Patol Oral Cir Bucal. 2022. PMID: 35218643 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical